U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C21H38N.Br
Molecular Weight 384.437
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BENZODODECINIUM BROMIDE

SMILES

[Br-].CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1

InChI

InChIKey=KHSLHYAUZSPBIU-UHFFFAOYSA-M
InChI=1S/C21H38N.BrH/c1-4-5-6-7-8-9-10-11-12-16-19-22(2,3)20-21-17-14-13-15-18-21;/h13-15,17-18H,4-12,16,19-20H2,1-3H3;1H/q+1;/p-1

HIDE SMILES / InChI

Molecular Formula BrH
Molecular Weight 80.912
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C21H38N
Molecular Weight 304.5331
Charge 1
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Benzododecinium, a quaternary ammonium compound, is an antiseptic agent and disinfectant. Benzododecinium is used as preservative in different pharmaceutical formulations. Thus, the dispenser of Timoptol-LA, used for the treatment of patients with ocular hypertension, contains benzododecinium bromide as a preservative. It is used as preservative and the corneal permeability enhancer in formulation. Benzododecinium is effective against gram-positive microbes.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells.
2001 Mar
Counterion effects on interaction of amphiphilic quaternary ammonium salts with model membranes.
2001 May-Jun
Controlled drug release from gels using surfactant aggregates. II. Vesicles formed from mixtures of amphiphilic drugs and oppositely charged surfactants.
2001 Nov
Mikrocalorimetric studies on the interaction of N-dodecyl-N,N-dimethyl-N-benzylammonium halides with phosphatidylcholine bilayers: a counterion effect.
2002
Interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers-the effect of counterions.
2003 Apr
Speciation of vanadium in soil.
2003 Jan 2
Bactericidal treatment of raw cotton as the method of byssinosis prevention.
2003 Jan-Feb
Sterol and sterolin-containing products: hematologic adverse reactions.
2004 Apr 13
Adverse drug reactions in Canada. Hematologic reactions to sterol and sterolin-containing products.
2004 Aug
Analysis of benzyldimethyldodecylammonium bromide in chemical disinfectants by liquid chromatography and capillary electrophoresis.
2004 Jun 11
[Preformulation studies of potential drug XIX M: partition coefficient].
2005 Mar
Architecture of the hydrophobic and hydrophilic layers as found from crystal structure analysis of N-benzyl-N,N-dimethylalkylammonium bromides.
2005 Oct 1
Identification of benzalkonium chloride in commercial grapefruit seed extracts.
2005 Sep 21
Molecular mechanism and thermodynamics study of plasmid DNA and cationic surfactants interactions.
2006 Apr 11
Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
2006 Mar 27
The influence of cholesterol on the interaction between N-dodecyl-N,N-dimethyl-N-benzylammonium halides and phosphatidylcholine bilayers.
2006 Mar-Apr
Instrument processing with lauryl dimethyl benzyl ammonium bromide: a challenge for patient safety.
2008 Oct
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide: II. Volumetric properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009 Feb 15
Surface and volume properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide I. Surface properties of dodecylethyldimethylammonium bromide and benzyldimethyldodecylammonium bromide.
2009 Mar 15
Synthesis of macroporous thermosensitive hydrogels: a novel method of controlling pore size.
2009 Mar 3
In situ forming polymeric drug delivery systems.
2009 May
The use of quaternary ammonium disinfectants selects for persisters at high frequency from some species of non-tuberculous mycobacteria and may be associated with outbreaks of soft tissue infections.
2010 Dec
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The design proposed the optimized batch by selecting the independent variables as gellan gum (0.55% w/v), carbopol 934P (0.35% w/v) and benzododecenium bromide (0.013% w/v) to achieve the maximum viscosity
Ophthalmic use: The 25 uL of test sample was instilled in the lower conjunctival sac of eye and holded for 10 seconds.
Route of Administration: Topical
In Vitro Use Guide
Curator's Comment: The mechanism of action of benzyldimethyldodecylammonium chloride (Benzododecinium chloride) was assessed against Pseudomonas fluorescens.
The MIC was found to be 20 mg/L and the MBC was 10 mg/L
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:57:27 UTC 2023
Edited
by admin
on Fri Dec 15 15:57:27 UTC 2023
Record UNII
IRY12B2TQ6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BENZODODECINIUM BROMIDE
II   MART.   WHO-DD  
Common Name English
N-DODECYL-N,N-DIMETHYLBENZENEMETHANAMINIUM BROMIDE
Systematic Name English
Benzododecinium bromide [WHO-DD]
Common Name English
BENZENEMETHANAMINIUM, N-DODECYL-N,N-DIMETHYL-, BROMIDE
Systematic Name English
BENZODODECINIUM BROMIDE [MART.]
Common Name English
AMMONIUM, BENZYLDODECYLDIMETHYL-, BROMIDE
Systematic Name English
BENZODODECINIUM BROMIDE [II]
Common Name English
LAURALKONIUM BROMIDE
INCI  
INCI  
Official Name English
LAURALKONIUM BROMIDE [INCI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
Code System Code Type Description
DAILYMED
IRY12B2TQ6
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
CAS
7281-04-1
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
NCI_THESAURUS
C76255
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
PUBCHEM
23705
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
ECHA (EC/EINECS)
230-698-4
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
FDA UNII
IRY12B2TQ6
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
RXCUI
1311594
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY RxNorm
EPA CompTox
DTXSID4048698
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
EVMPD
SUB00725MIG
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
SMS_ID
100000085001
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
WIKIPEDIA
BENZODODECINIUM BROMIDE
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
CHEBI
167207
Created by admin on Fri Dec 15 15:57:27 UTC 2023 , Edited by admin on Fri Dec 15 15:57:27 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY